Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2026-01-02 00:00:00 ET · period of report 2025-12-31 · accession 0001614740-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-01-02 | 2025-12-31 | MIRM | Peetz Christopher | CEO, Dir | G - Gift | $0.00 | -21.1K | 187.5K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-31 | G | D | 21,070 | $0.00 | 187,500 | I By The Peetz Family Trust | — | — |